Copyright
©The Author(s) 2016.
World J Gastrointest Surg. Apr 27, 2016; 8(4): 284-293
Published online Apr 27, 2016. doi: 10.4240/wjgs.v8.i4.284
Published online Apr 27, 2016. doi: 10.4240/wjgs.v8.i4.284
Table 2 Nucleotide-binding and oligomerization-domain containing 2 polymorphisms and cancer risk: Results of meta-analysis
Meta-analysis | Liu et al[37] (2014) | Tian et al[41] (2010) | |
R702W | |||
Variant genotypes vs homozygous wild-type | OR | 1.32 | 1.59 |
95%CI | 1.01-1.72 | 1.09-2.32 | |
P value | 0.04 | 0.02 | |
G908R | |||
Variant genotypes vs homozygous wild-type | OR | 1.32 | 1.98 |
95%CI | 1.01-1.72 | 1.14-3.44 | |
P value | 0.04 | 0.01 | |
3020insC | |||
Variant genotypes vs homozygous wild-type | OR | 1.23 | 1.44 |
95%CI | 1.10-1.38 | 1.13-1.84 | |
P value | < 0.001 | 0.003 | |
R702W/G908R/3020insC | |||
Variant genotypes vs homozygous wild-type | OR | - | 1.58 |
95%CI | - | 1.03-2.42 | |
P value | - | 0.03 |
- Citation: Branquinho D, Freire P, Sofia C. NOD2 mutations and colorectal cancer - Where do we stand? World J Gastrointest Surg 2016; 8(4): 284-293
- URL: https://www.wjgnet.com/1948-9366/full/v8/i4/284.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v8.i4.284